Science Explorer Interactive view Map
Research facility · Seongnam-si · South Korea

KoreaBio

koreabio.org/main.doROR OpenAlex
Research works
21
▲ 190% vs 2013–17
Citations
166
8.1 per fractional work
Top-10% rate
11.5%
record average 16.5%
Open access
56%
world 28%

Not ranked overall: KoreaBio is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.65× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.69× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 6.84× its world share, 1 worksImmunology and Micro…Neuroscience: 1.08× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.21× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.32× its world share, 0 worksChemistryComputer Science: 0.32× its world share, 0 worksComputer ScienceEngineering: 0.48× its world share, 1 worksEngineeringEnvironmental Science: 0.17× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.54× its world share, 0 worksMaterials ScienceDentistry: 1.03× its world share, 0 worksDentistryMedicine: 1.95× its world share, 5 worksMedicineVeterinary: 9.24× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 9.2×. Every wedge is a field page.

Which research topics does KoreaBio publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Cancer Research and Treatments, RNA modifications and cancer and Cancer, Hypoxia, and Metabolism.

Monoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer Research and Treatments: 1 fractional worksRNA modifications and ca…1RNA modifications and cancer: 1 fractional worksCancer, Hypoxia, and Met…0Cancer, Hypoxia, and Metabolism: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksAdipokines, Inflammation, and Metabolic Diseases: 0 fractional worksFibroblast Growth Factor…0Fibroblast Growth Factor Research: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksImmune cells in cancer0Immune cells in cancer: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional works
Radiology, Nuclear Medicine and ImagingBiotechnologyMolecular BiologyCancer Research4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Cancer Research and Treatments Biotechnology 1 works
  3. 3 RNA modifications and cancer Molecular Biology 1 works
  4. 4 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  5. 5 HER2/EGFR in Cancer Research Oncology 0 works
  6. 6 Adipokines, Inflammation, and Metabolic Diseases Epidemiology 0 works
  7. 7 Fibroblast Growth Factor Research Molecular Biology 0 works
  8. 8 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  9. 9 Immune cells in cancer Immunology 0 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available56.5%not open43.5%

World: 28% of research is openly available.

with international co-authors28.0%domestic only72.0%

World: 19% is written across borders.

How has KoreaBio's research output changed?

Output in 2018–2022 was 190% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seongnam-si

All research institutions in Seongnam-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.